Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

4.3%

1 terminated/withdrawn out of 23 trials

Success Rate

94.1%

+7.6% vs industry average

Late-Stage Pipeline

17%

4 trials in Phase 3/4

Results Transparency

0 of 16 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

9(56.3%)

Phase 2

3(18.8%)

Phase 3

2(12.5%)

Phase 4

2(12.5%)

16Total

N/A(9)

Phase 2(3)

Phase 3(2)

Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (23)

Showing 20 of 23 trials

NCT01198483Not ApplicableUnknown

Microincision Versus Smallincision Combined Surgery

Role: lead

NCT00757380Not ApplicableCompleted

Trypan Blue Versus Brillant Blue for Epiretinal Membranes

Role: lead

NCT01477996Not ApplicableCompleted

Pain After Intravitreal Therapy

Role: lead

NCT00757471Not ApplicableCompleted

Brillant Blue Versus Indocyanine Green for Macular Hole Surgery

Role: lead

NCT00757536Not ApplicableCompleted

Primary Vitrectomy With Endolaser or Encircling Band for Rhegmatogenous Retinal Detachment

Role: lead

NCT01570608Phase 3Completed

Lucentis KAV Study

Role: lead

NCT00885794Phase 2Unknown

Microperimetry and Optical Coherence Tomography (OCT) With Lucentis for Diabetic Macular Edema (DME)

Role: lead

NCT00443911Unknown

Rheohemapheresis and Lutein Supplementation in the Non-Exsudative Form of Age-Related Macular Degeneration

Role: lead

NCT01165801Phase 4Completed

Size Progression of Macular Degeneration After Cataract Surgery

Role: lead

NCT00926861Unknown

Posterior Macular Adhesion: A Potential Risk Factor for Non-exudative Age Related Macular Degeneration (AMD) to Develop Exudative AMD

Role: lead

NCT00927303Completed

The Spectralis-Cirrus Study

Role: lead

NCT00710229Phase 3Unknown

Manta Study: Avastin Versus Lucentis in Age Related Macular Degeneration

Role: lead

NCT00531336Phase 2Completed

MAAM Study: Avastin and Macugen Versus Avastin Versus Macugen

Role: lead

NCT00531141Completed

The Optical Coherence Tomography in Age-Related Macular Degeneration Study: The OCT in AMD Study

Role: lead

NCT00531024Phase 2Completed

Systemic Avastin Therapy in Age-Related Macular Degeneration

Role: lead

NCT00444249Not ApplicableTerminated

Influence of Blue Light Filtering Intraocular Lenses on Daytime Levels of Melatonin

Role: lead

NCT00555269Completed

Membrane Blue Versus Infracyanine Green

Role: lead

NCT00437593Not ApplicableCompleted

UHR-OCT and HD-OCT for Preretinal Membranes: ICG Versus Membrane Blue

Role: lead

NCT00401713Not ApplicableCompleted

Transplantation of Autologous RPE Versus Translocation of Autologous RPE and Choroid in AMD

Role: lead

NCT00643422Completed

Reproducibility of Cirrus Optical Coherence Tomography Measurements

Role: lead